Neutron autoradiography to study boron compound microdistribution in an oral cancer model

Purpose : We previously reported the therapeutic effi cacy of Sequential Boron Neutron Capture Therapy (Seq-BNCT), i.e., BPA (boronophenylalanine) ? BNCT followed by GB-10 (decahydrodecaborate) ? BNCT 1 or 2 days later, in the hamster cheek pouchoral cancer model. We have utilized the neutron autora...

Descripción completa

Detalles Bibliográficos
Autores: Portu, Agustina Mariana, Molinari, Ana Julia, Thorp, Silvia Inés, Pozzi, Emiliano César Cayetano, Curotto, Paula, Schwint, Amanda Elena, Saint Martin, María Laura Gisela
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:Argentina
Institución:Consejo Nacional de Investigaciones Científicas y Técnicas
Repositorio:CONICET Digital (CONICET)
Idioma:inglés
OAI Identifier:oai:ri.conicet.gov.ar:11336/111429
Acceso en línea:http://hdl.handle.net/11336/111429
Access Level:acceso abierto
Palabra clave:NEUTRON AUTORADIOGRAPHY
BORON MICRODISTRIBUTION
SEQUENTIAL BNCT
GB-10
BPA
ORAL CANCER
https://purl.org/becyt/ford/1.3
https://purl.org/becyt/ford/1
Descripción
Sumario:Purpose : We previously reported the therapeutic effi cacy of Sequential Boron Neutron Capture Therapy (Seq-BNCT), i.e., BPA (boronophenylalanine) ? BNCT followed by GB-10 (decahydrodecaborate) ? BNCT 1 or 2 days later, in the hamster cheek pouchoral cancer model. We have utilized the neutron autoradiography methodology to study boron microdistribution in tissue.The aim was to use this method to evaluate if the distribution of GB-10 is altered by prior application of BPA-BNCT in Sequential BNCT protocols.Materials and methods : Extensive qualitative and quantitative autoradiography analyses were performed in the following groups: G1 (animals without boron); G2 (animals injected with BPA); G3 (animals injected with GB-10); G4 (same as G3, 24 h after BPA-BNCT); and G5 (same protocol as G4, 48 h interval).Results : A detailed study of boron localization in the diff erent tissue structures of tumor, premalignant and normal tissue in the hamster cheek pouch was performed. GB-10 accumulated preferentially in non-neoplastic connective tissue, whereas for BPA neoplastic cells showed the highest boron concentration. Boron distribution was less heterogeneous for GB-10 than for BPA. In premalignant and normal tissue, GB-10 and BPA accumulatedmostly in connective tissue and epithelium, respectively.Conclusions : BPA-BNCT could alter boron microlocalization of GB-10 administered subsequently. Boron targeting homogeneity is essential for therapeutic success.